Wikidata entity: Q2146170
C₁₆H₁₈FN₃O₂ (P274)
Quantities
| P4250 | defined daily dose | 0.9 |
| P2067 | mass | 303.138305 |
| P3780 | active ingredient in | ... | Q29006601 (Trobalt) | Trobalt |
| P3780 | active ingredient in | ... | Q47522007 (Potiga) | Potiga |
| P233 | canonical SMILES | String | CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N | ??? |
| P373 | Commons category | String | Retigabine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P129 | physically interacts with | ... | Q6449560 (Potassium voltage-gated channel subfamily Q member 1) | Potassium voltage-gated channel subfamily Q member 1 |
| P129 | physically interacts with | ... | Q6449561 (Potassium voltage-gated channel subfamily Q member 2) | Potassium voltage-gated channel subfamily Q member 2 |
| P129 | physically interacts with | ... | Q6449562 (Potassium voltage-gated channel subfamily Q member 3) | Potassium voltage-gated channel subfamily Q member 3 |
| P129 | physically interacts with | ... | Q21108785 (Potassium voltage-gated channel subfamily Q member 4) | Potassium voltage-gated channel subfamily Q member 4 |
| P129 | physically interacts with | ... | Q21108789 (Potassium voltage-gated channel subfamily Q member 5) | Potassium voltage-gated channel subfamily Q member 5 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q50430321 (membrane transport modulator) | membrane transport modulator |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | retigabine | ??? |
| P267 | ATC code | N03AX21 |
| P231 | CAS Registry Number | 150812-12-7 |
| P683 | ChEBI ID | 68584 |
| P592 | ChEMBL ID | CHEMBL41355 |
| P661 | ChemSpider ID | 108740 |
| P715 | DrugBank ID | DB04953 |
| P11198 | DrugCentral ID | 4181 |
| P8494 | DSSTOX compound identifier | DTXCID5087106 |
| P3117 | DSSTox substance ID | DTXSID40164615 |
| P232 | EC number | 629-886-2 |
| P2566 | ECHA Substance Infocard ID | 100.158.123 |
| P646 | Freebase ID | /m/05q4_qf |
| P595 | Guide to Pharmacology Ligand ID | 2601 |
| P2062 | HSDB ID | 8171 |
| P2057 | Human Metabolome Database ID | HMDB0257171 |
| P234 | InChI | InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21) |
| P235 | InChIKey | PCOBBVZJEWWZFR-UHFFFAOYSA-N |
| P665 | KEGG ID | D09569 |
| P665 | KEGG ID | C13826 |
| P244 | Library of Congress authority ID | sh2014100119 |
| P7830 | LiverTox ID | Ezogabine |
| P10245 | MedlinePlus drug identifier | a612028 |
| P486 | MeSH descriptor ID | C101866 |
| P6366 | Microsoft Academic ID (discontinued) | 2778994288 |
| P8189 | National Library of Israel J9U ID | 987007407424805171 |
| P2115 | NDF-RT ID | N0000182972 |
| P3636 | PDB ligand ID | FBX |
| P11199 | Probes And Drugs ID | PD009342 |
| P662 | PubChem CID | 121892 |
| P1579 | Reaxys registry number | 8072099 |
| P3345 | RxNorm CUI | 1112990 |
| P2877 | SureChEMBL ID | 20835 |
| P2892 | UMLS CUI | C0530684 |
| P11089 | UniChem compound ID | 116007 |
| P652 | UNII | 12G01I6BBU |
Why not click here or view trends?
log id: 2287986